What: BeyondSpring Inc. (Nasdaq:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).